Advertisement

Topics

NextCure secures $93m funds to support clinical development of two drug candidates

05:21 EST 14 Nov 2018 | Pharmaceutical Business Review

The financing was led by Hillhouse Capital Management and Quan Capital, and included Bay City Capital, Surveyor Capital (a Citadel company), Ping An Ventures, Taiho Ventures LLC, ArrowMark

The post NextCure secures $93m funds to support clinical development of two drug candidates appeared first on Pharmaceutical Business review.

Original Article: NextCure secures $93m funds to support clinical development of two drug candidates

NEXT ARTICLE

More From BioPortfolio on "NextCure secures $93m funds to support clinical development of two drug candidates"

Advertisement
Quick Search
Advertisement
Advertisement